Stockholders’ Equity (Tables)

3 Months Ended

Mar. 31, 2026

Equity [Abstract]

Schedule of Preferred Stock

Of the 2,000,000 shares of preferred stock authorized, the Company’s board of directors has designated (all with par value of $0.001 per share) the following:

	As of March 31, 2026					As of December 31, 2025
	Preferred Shares Outstanding	Liquidation Preference (Per Share)		Total Liquidation Preference		Preferred Shares Outstanding	Liquidation Preference (Per Share)		Total Liquidation Preference
Series C-3	2,000	$	10.00	$	20,000	2,000	$	10.00	$	20,000
Series E	89,623	$	62.76	$	5,624,739	89,623	$	62.76	$	5,624,739
Total	91,623			$	5,644,739	91,623			$	5,644,739

Schedule of Fair Value of the PSUs Granted

The following key assumptions were used to determine the fair value of the PSUs granted during the period:

Assumption	Period 1			Period 2		Period 3
2025 Grant
Share price	$	8.10		N/A		N/A
Equity volatility	71.2		%	69.7%		87%
Remaining term (years)	0.99			1.99		2.99
Dividend yield	0		%	0	%	0	%
Risk-free rate	4.1		%	4.2	%	4.3	%
2026 Grant
Share price	$	7.27		N/A		N/A
Equity volatility	87.3		%	81.8%		77.6%
Remaining term (years)	1.02			2.02		3.02
Dividend yield	0		%	0	%	0	%
Risk-free rate	3.5		%	3.6	%	3.7	%

Schedule of Condensed Consolidated Statements of Operations

Total stock-based compensation expense recognized in the condensed consolidated statements of operations is as follows:

	Three Months Ended March 31,
Award type	2026		2025
RSUs	$	3,340	$	2,079
PSUs	716		479
Stock options	526		942
Total	$	4,582	$	3,500

Schedule of Stock-Based Compensation Expense by Financial Statement

	Three Months Ended March 31,
Financial statement line item	2026		2025
Cost of sales	$	192	$	55
Research and development	278		124
Selling and marketing	622		113
General and administrative	3,490		3,208
Total	$	4,582	$	3,500